Glutamate and Its Receptors as Therapeutic Targets for Migraine
Neurotherapeutics - United States
doi 10.1007/s13311-018-0616-5
Full Text
Open PDFAbstract
Available in full text
Date
March 5, 2018
Authors
Publisher
Springer Science and Business Media LLC